BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26006791)

  • 1. Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning.
    Foley JM; Salat DH; Stricker NH; McGlinchey RE; Milberg WP; Grande LJ; Leritz EC
    Am J Alzheimers Dis Other Demen; 2016 Feb; 31(1):76-86. PubMed ID: 26006791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history of Alzheimer's disease and hippocampal structure in healthy people.
    Donix M; Burggren AC; Suthana NA; Siddarth P; Ekstrom AD; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Small GW; Bookheimer SY
    Am J Psychiatry; 2010 Nov; 167(11):1399-406. PubMed ID: 20686185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.
    Gutiérrez-Galve L; Lehmann M; Hobbs NZ; Clarkson MJ; Ridgway GR; Crutch S; Ourselin S; Schott JM; Fox NC; Barnes J
    Dement Geriatr Cogn Disord; 2009; 28(5):476-85. PubMed ID: 19940480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
    Wolk DA; Dickerson BC;
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
    Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitively normal individuals with AD parents may be at risk for developing aging-related cortical thinning patterns characteristic of AD.
    Reiter K; Alpert KI; Cobia DJ; Kwasny MJ; Morris JC; Csernansky JC; Wang L
    Neuroimage; 2012 Jul; 61(3):525-32. PubMed ID: 22503937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism.
    Donix M; Burggren AC; Suthana NA; Siddarth P; Ekstrom AD; Krupa AK; Jones M; Rao A; Martin-Harris L; Ercoli LM; Miller KJ; Small GW; Bookheimer SY
    Neuroimage; 2010 Oct; 53(1):37-43. PubMed ID: 20541611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4.
    Espeseth T; Westlye LT; Fjell AM; Walhovd KB; Rootwelt H; Reinvang I
    Neurobiol Aging; 2008 Mar; 29(3):329-40. PubMed ID: 17161508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.
    Donix M; Burggren AC; Scharf M; Marschner K; Suthana NA; Siddarth P; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Werner A; von Kummer R; Sauer C; Small GW; Holthoff VA; Bookheimer SY
    Psychiatry Res; 2013 Dec; 214(3):212-20. PubMed ID: 24080518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precuneus degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural and functional MRI analyses.
    Chen Y; Liu Z; Zhang J; Chen K; Yao L; Li X; Gong G; Wang J; Zhang Z
    Hum Brain Mapp; 2017 Jan; 38(1):271-282. PubMed ID: 27593520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.
    Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY
    Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
    Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O
    Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting-state network disruption and APOE genotype in Alzheimer's disease: a lagged functional connectivity study.
    Canuet L; Tellado I; Couceiro V; Fraile C; Fernandez-Novoa L; Ishii R; Takeda M; Cacabelos R
    PLoS One; 2012; 7(9):e46289. PubMed ID: 23050006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
    Pievani M; Rasser PE; Galluzzi S; Benussi L; Ghidoni R; Sabattoli F; Bonetti M; Binetti G; Thompson PM; Frisoni GB
    Neuroimage; 2009 May; 45(4):1090-8. PubMed ID: 19349226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
    Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J;
    Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging.
    Tosun D; Mojabi P; Weiner MW; Schuff N
    Neuroimage; 2010 Aug; 52(1):186-97. PubMed ID: 20406691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults.
    Foley JM; Salat DH; Stricker NH; Zink TA; Grande LJ; McGlinchey RE; Milberg WP; Leritz EC
    Am J Alzheimers Dis Other Demen; 2014 May; 29(3):222-35. PubMed ID: 24381137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.